Page 16 - UHN-RR2021
P. 16

RESEARCH MCEWEN STEM CELL INSTITUTE





                Stem Cells



               to Liver



               Cells





               Scientists create liver cells with

               vital blood-clotting protein


               Researchers have found a way to generate the
               cells that may hold the key to new treatments
               for hemophilia A, a genetic disorder in which the
               blood does not clot normally.


               The cells that were produced are known as liver
               sinusoidal endothelial cells and are found in
               specific regions of the liver. The research team
               made the cells from human pluripotent stem cells,
               which can give rise to most cells in the human
               body.
                                                                 Dr. Keller concludes, “This finding moves us
               “Individuals with hemophilia A lack a clotting    closer to understanding the role of these cells in
               factor known as Factor VIII, which is produced    liver function and to developing new therapies to
               by these endothelial cells. We found a way to make   treat a number of conditions, such as hemophilia A
               large numbers of the precursors of these cells in   and chronic liver diseases.”
               the laboratory, and we were able to validate that
               they can make the missing clotting factor,” says Dr.   Gage BK, et al. Cell Stem Cell. 2020 July 7. doi:10.1016/j.
               Blair Gage, a postdoctoral fellow in Dr. Gordon   stem.2020.06.007. Supported by the University of Toronto’s
               Keller’s laboratory and first author of the study.   Medicine by Design Initiative, which receives funding from
                                                                 the Canada First Research Excellence Fund; the Canadian
                                                                 Institutes of Health Research; the McEwen Stem Cell Institute;
               The team first used human pluripotent stem cells   and the UHN Foundation.
               to generate venous angioblasts—precursors to
               the endothelial cells that line the veins. Next, by   (Top left) Immunofluorescence image showing human
               transplanting these precursors into experimental   pluripotent stem cell-derived liver endothelial cells. The cells
               models, the researchers were able to coax them to   are stained red and green with white nuclei. A blood factor
                                                                 related to Factor VIII, known as Von Willebrand Factor,
               mature into sinusoidal endothelial cells that were   is stained in blue. (Top right) Dr. Blair Gage. (Right) Dr.
               capable of producing Factor VIII.                 Alexander Mikryukov.





                14
   11   12   13   14   15   16   17   18   19   20   21